imo, prepare yourself for positive news.
of course the fda could nitpick on the early dosage data in some way or another, but there has been way too much positive research and successful stem cell application in the lab here and in humans abroad, not to be extremely positive and bullish.
As I've posted before, as a longtime investor, like so many others here, I believe ACTC is one of those once in a lifetime finds and could prove to be the investment of the century as it relates to the field of medicine.